Russia's self-medication market is developing fast, with sales growingin excess of 30% per annum, according to a report from Nicholas Hall & Co, entitled OTC Opportunities in Emerging Markets: Former Soviet Union.
Multinationals which already have a strong presence in the sector include Warner-Lambert, Procter & Gamble and Johnson & Johnson. Looking at individual product sectors, it notes particularly strong growth in cough/cold and analgesic products, which totaled sales of $300 million in 1995, 75% of which was sold without prescription.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze